首页> 外文期刊>Archives of surgery. >Prospective clinical trials of thyroidectomy with LigaSure vs conventional vessel ligation: a systematic review and meta-analysis.
【24h】

Prospective clinical trials of thyroidectomy with LigaSure vs conventional vessel ligation: a systematic review and meta-analysis.

机译:甲状腺切除术对甲状腺切除术的前瞻性临床试验与常规血管结扎:系统评论和荟萃分析。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To evaluate the hemostatic effects and safety of thyroidectomy performed using the LigaSure vessel-sealing device (Valleylab, Boulder, Colorado) or the conventional vessel ligation. DATA SOURCES: The MEDLINE, EMBASE, Elsevier, SpringerLink, Ovid, and Cochrane Library electronic databases as well as the LigaSure manufacturer's Web site were searched for studies published between 1996 and 2008. No language restrictions were applied. STUDY SELECTION: Prospective, controlled clinical trials, both randomized and nonrandomized, comparing the hemostatic effects and safety of thyroidectomy using LigaSure and conventional vessel ligation were selected. DATA EXTRACTION: Data regarding operative parameters, duration of the operation, amount of intraoperative blood loss, length of hospital stay, and any postoperative complications were entered and analyzed using dedicated software from the Cochrane Collaboration. DATA SYNTHESIS: Four randomized and 5 nonrandomized trials that met selection criteria reported data from 927 patients, of whom 467 (50.4%) underwent LigaSure and 460 (49.6%) underwent conventional thyroidectomy. Operative duration (weighted mean difference [WMD], -11.97 minutes; 95% confidence interval [CI], -16.42 to -7.53 minutes) was significantly reduced with LigaSure thyroidectomy (P < .001). When LigaSure was used, operative time reductions of 20.32 minutes (95% CI, -33.86 to -6.79 minutes) for total thyroidectomy (P = .003) and 21.74 minutes (-38.32 to -5.16 minutes) for subtotal thyroidectomy (P = .01) were also confirmed with subgroup analysis. However, differences in the amount of intraoperative blood loss (WMD, -25.13 mL; 95% CI, -68.45 to 18.18 mL; P = .26), length of hospital stay (WMD, -0.08 days; 95% CI, -0.23 to 0.08 days; P = .31), and postoperative complication rates (odds ratio, 0.91; 95% CI, 0.61-1.04; P = .65) were not statistically significant for LigaSure vs conventional thyroidectomy. CONCLUSIONS: The LigaSure technique may provide a safe, effective, and fast alternative to conventional vessel ligation in thyroidectomy and may result in a significant reduction in operative duration. However, it may not confer any advantage over conventional thyroidectomy in terms of the amount of intraoperative blood loss, length of hospital stay, and postoperative complication rates.
机译:目的:评价使用LIGASURE血管密封装置(Valleylab,Boulder,Colorado)或常规血管连接进行甲状腺切除术的止血效应和安全性。数据来源:搜索了MEDLINE,EMBASE,ELSEVIER,SPRINGERLINK,OVID和Cochrane库电子数据库以及LIGASURE制造商的网站,以便于1996年至2008年期间发布的研究。没有应用语言限制。研究选择:预期,受控临床试验,随机和非沉积,比较使用LIGAURURE和常规血管连接的甲状腺切除术的止血效果和安全性。数据提取:关于手术参数的数据,操作持续时间,术中失血量,医院住院长度以及任何术后并发症都是使用Cochrane合作的专用软件分析。数据合成:四种随机和5个非扫描试验,其符合来自927名患者的数据的选择标准,其中467(50.4%)接受了高血压和460(49.6%)进行的常规甲状腺切除术。操作持续时间(加权平均差异[WMD],-11.97分钟; 95%置信区间[CI],-16.42至-7.53分钟)随着LIGASURE甲状腺切除术而显着降低(P <.001)。当使用LIGASURE时,对于小甲状腺切除术(P = .003)和21.74分钟(-38.32至-5.16分钟),可操作时间减少20.32分钟(95%CI,-33.86至-6.79分钟)(p =。 01)也用亚组分析证实。然而,术中失血量(WMD,-25.13ml; 95%CI,-68.45至18.18ml; p = .26),住院时间(WMD,-0.08天; 95%CI,-0.23至0.08天; p = .31)和术后并发症率(差距比,0.91; 95%CI,0.61-1.04; p = .65)对于LIGASURE与常规甲状腺切除术没有统计学意义。结论:LIGASURE技术可提供甲状腺切除术中的常规血管结扎的安全,有效和快速替代,并且可能导致操作持续时间显着降低。然而,在术中失血量,住院时间长度和术后并发症率方面,它可能不会赋予常规甲状腺切除术的任何优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号